Controlled pore size of Pt/KIT-6 used for propane total oxidation

来源 :稀有金属(英文版) | 被引量 : 0次 | 上传用户:qqwj
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Mesoporous silica KIT-6 with different pore sizes was controllably synthesized by hydrothermal methods.The same contents of Pt were loaded on KIT-6 supports to apply for propane total oxidation.Low-angle X-ray diffraction (XRD),nitrogen adsorption-desorption,CO chemisorption and transmission electron microscopy (TEM) were carried out to investigate the physicochemical properties of the catalysts.The results reveal that different pore sizes of KIT-6 supports could affect the Pt particle sizes on KIT-6.The mesopores on KIT-6-80 and KIT-6-130 effectively confine the size of the inside Pt nanoparticles during calcining.Pt/KIT-6-80 with the appropriate pore size as well as the Pt particle size exhibits the best catalytic performance with T50 (the temperature at which hydrocarbon (HC) conversion reaches 50%) of only 237 ℃.However,Pt particles prefer dispersing on the extal surface of KIT-6-40 due to those too small pores.
其他文献
通过采用循环交叉轧制(每轧一次旋转90°,4次叫一个循环)的方式,研究其对ZK60镁合金棒材组织和性能的影响.采用金相显微镜(OM),X射线衍射(XRD),电子扫描电镜(SEM),透射电镜(T
采用电弧增强磁控溅射(AEMS)技术在钛表面制备纳米复合Si-C-N超硬薄膜,研究薄膜的显微结构、相组成、硬度、韧性、摩擦学行为和耐蚀性能。结果表明,薄膜形成了C–C、C=C、N–
Carbon and few-layer MoS2 nanosheets co-modified TiOa nanocomposites (defined as MoS2-C@TiO2)were prepared through a facile one-step pyrolysis reaction techniqu
近年来,不同急性白血病亚型与预后及疗效的关系,已引起各国血液学工作者的广泛重视。1976年,Bennett 等报道了FAB 协作组根据细胞形态学和组织化学所提出的急性白血病分类标
内分泌病是一种可影响身体各个脏器的周身性疾患,其中多数影响心血管系统,有时甚至以心血管系统症状、体征为主要或唯一临床表现,往往造成原发内分泌病的误诊或漏诊。内分泌
利用电液伺服材料试验机,对直径为Φ16的TA18(Ti-3Al-2.5V)钛合金管材试样分别在–60,25,100,200,300和350℃下进行了静态拉伸试验,并结合TEM观察TA18钛合金管材在高低温下的
左心功能测定对临床的诊断、治疗、观察等都有重要意义。过去多用心导管或心血管造影等方法进行测定,因其为创伤性,且设备操作复杂,不易推广。近10多年来应用超声心动图检测
The NbO electrode materials were successfully synthesized by high-temperature solid-phase method using Nb powders and Nb2O5 powders as raw materials.The crystal
本文通过对荣华二采区10
期刊
复发性口腔溃疡是最常见的口腔粘膜病。但由于病因不明,故至今没有一个有效的治疗方法。近年来对本病进行了免疫学研究,并用一些免疫制剂进行治疗。我科从1981年开始用左旋